Medtronic's Micra Leadless Pacemaker Approved for Reimbursement in U.S.

In a big leap forward for the use of leadless pacemakers, U.S. Centers for Medicare& Medicaid Services (CMS) today approved reimbursement coverage for Medtronic's Micra ® Transcatheter Pacing System (TPS), the only FDA-approved leadless pacing system. A major advantage of leadless pacemakers is that they can be implanted via catheter, in a similar fashion to angioplasty, so no surgical incision or pocket is necessary.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news